780 related articles for article (PubMed ID: 36069224)
1. [Corrigendum] The novel anti‑neuroblastoma agent PF403, inhibits proliferation and invasion
Li C; Li Y; Lv H; Li S; Tang K; Zhou W; Yu S; Chen X
Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 36069224
[TBL] [Abstract][Full Text] [Related]
2. [Corrigendum] SB‑T‑121205, a next‑generation taxane, enhances apoptosis and inhibits migration/invasion in MCF‑7/PTX cells.
Zheng X; Wang C; Xing Y; Chen S; Meng T; You H; Ojima I; Dong Y
Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36484397
[TBL] [Abstract][Full Text] [Related]
3. [Corrigendum] miR‑200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non‑small cell lung cancer cells.
Tang Q; Li M; Chen L; Bi F; Xia H
Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36196896
[TBL] [Abstract][Full Text] [Related]
4. [Corrigendum] ANXA1‑derived peptides suppress gastric and colon cancer cell growth by targeting EphA2 degradation.
Feng J; Xiao T; Lu SS; Hung XP; Yi H; He QY; Huang W; Tang YY; Xiao ZQ
Int J Oncol; 2019 Nov; 58(1):133-134. PubMed ID: 33899924
[TBL] [Abstract][Full Text] [Related]
5. [Corrigendum] miR‑382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor‑associated macrophages by targeting PGC‑1α.
Zhou H; Gan M; Jin X; Dai M; Wang Y; Lei Y; Lin Z; Ming J
Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36331032
[TBL] [Abstract][Full Text] [Related]
6. [Corrigendum] High expression of FUSE binding protein 1 in breast cancer stimulates cell proliferation and diminishes drug sensitivity.
Liu W; Xiong X; Chen W; Li X; Hua X; Liu Z; Zhang Z
Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33887879
[TBL] [Abstract][Full Text] [Related]
7. [Corrigendum] S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway.
Wu R; Duan L; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L
Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36866758
[TBL] [Abstract][Full Text] [Related]
8. [Corrigendum] CXCR1 promotes malignant behavior of gastric cancer cells
Wang J; Hu W; Wu X; Wang K; Yu J; Luo B; Luo G; Wang W; Wang H; Li J; Wen J
Int J Oncol; 2023 Jun; 62(6):. PubMed ID: 37165903
[TBL] [Abstract][Full Text] [Related]
9. [Corrigendum] miR‑593 inhibits proliferation and invasion and promotes apoptosis in non‑small cell lung cancer cells by targeting SLUG‑associated signaling pathways.
Wei F; Wang M; Li Z; Wang Y; Zhou Y
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34878153
[TBL] [Abstract][Full Text] [Related]
10. [Corrigendum] Effect of duty cycles of tumor‑treating fields on glioblastoma cells and normal brain organoids.
Ye E; Lee JE; Lim YS; Yang SH; Park SM
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35894136
[TBL] [Abstract][Full Text] [Related]
11. [Corrigendum] METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma.
Li M; Xia M; Zhang Z; Tan Y; Li E; Guo Z; Fang M; Zhu Y; Hu Z
Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37503727
[TBL] [Abstract][Full Text] [Related]
12. [Corrigendum] High PLK4 expression promotes tumor progression and induces epithelial‑mesenchymal transition by regulating the Wnt/β‑catenin signaling pathway in colorectal cancer.
Liao Z; Zhang H; Fan P; Huang Q; Dong K; Qi Y; Song J; Chen L; Liang H; Chen X; Zhang Z; Zhang B
Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33955524
[TBL] [Abstract][Full Text] [Related]
13. [Corrigendum] Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells.
Liu Z; Liu J; Zhao L; Geng H; Ma J; Zhang Z; Yu D; Zhong C
Int J Oncol; 2023 Jul; 63(1):. PubMed ID: 37326030
[TBL] [Abstract][Full Text] [Related]
14. [Corrigendum] Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression.
Zhao S; Wu L; Kuang Y; Su J; Luo Z; Wang Y; Li J; Zhang J; Chen W; Li F; He Y; Tao J; Zhou J; Xu X; Peng C; Chen X
Int J Oncol; 2024 Jan; 64(1):. PubMed ID: 37997849
[TBL] [Abstract][Full Text] [Related]
15. [Corrigendum] The effect of NFATc1 on vascular generation and the possible underlying mechanism in epithelial ovarian carcinoma.
Li L; Yu J; Duan Z; Dang HX
Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35119078
[TBL] [Abstract][Full Text] [Related]
16. [Corrigendum] miR‑23a suppresses pancreatic cancer cell progression by inhibiting PLK‑1 expression.
Chen B; Zhu A; Tian L; Xin Y; Liu X; Peng Y; Zhang J; Miao Y; Wei J
Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35583007
[TBL] [Abstract][Full Text] [Related]
17. [Corrigendum] Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway.
Sun X; Xin S; Zhang Y; Jin L; Liu X; Zhang J; Mei W; Zhang B; Ma W; Ye L
Int J Oncol; 2024 Jan; 64(1):. PubMed ID: 38038145
[TBL] [Abstract][Full Text] [Related]
18. [Corrigendum] LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells
Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
Int J Oncol; 2022 Feb; 60(2):. PubMed ID: 35014687
[TBL] [Abstract][Full Text] [Related]
19. [Corrigendum] Repression of Smad4 by miR‑205 moderates TGF‑β-induced epithelial‑mesenchymal transition in A549 cell lines.
Zeng Y; Zhu J; Shen D; Qin H; Lei Z; Li W; Huang JA; Liu Z
Int J Oncol; 2021 Feb; 58(2):276-277. PubMed ID: 33491753
[TBL] [Abstract][Full Text] [Related]
20. [Corrigendum] Knockdown of SNHG15 suppresses renal cell carcinoma proliferation and EMT by regulating the NF‑κB signaling pathway.
Du Y; Kong C; Zhu Y; Yu M; Li Z; Bi J; Li Z; Liu X; Zhang Z; Yu X
Int J Oncol; 2022 Apr; 60(4):. PubMed ID: 35191514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
